Difference between revisions of "Team:Paris Bettencourt/Proteins Caging"

Line 160: Line 160:
 
                             </p>
 
                             </p>
 
                             <div >
 
                             <div >
−
                                     <img id="fig5" src="https://static.igem.org/mediawiki/2017/0/01/Aya_figure8.png"/>  
+
                                     <img id="fig8" src="https://static.igem.org/mediawiki/2017/0/01/Aya_figure8.png"/>  
 
                                 </div>
 
                                 </div>
 
                                     <span  class="image-span text-center">
 
                                     <span  class="image-span text-center">
−
                                             <b>Figure5:</b> A diagram of the design of  Dronpa-T7RNAP constructs.
+
                                             <b>Figure8:</b> A diagram of the design of  Dronpa-T7RNAP constructs.
  
 
                                     </span>
 
                                     </span>
Line 173: Line 173:
 
                             </p>
 
                             </p>
 
                             <div >
 
                             <div >
−
                                     <img id="fig6" src="https://static.igem.org/mediawiki/2017/a/a9/Aya_figure_9.png" />  
+
                                     <img id="fig9" src="https://static.igem.org/mediawiki/2017/a/a9/Aya_figure_9.png" />  
 
                                 </div>
 
                                 </div>
 
                                     <span  class="image-span text-center">
 
                                     <span  class="image-span text-center">
−
                                             <b>Figure 6: </b>  A) The structure of T7 RNAP binding DNA (PDB: 1t7p)  B)The prediction of the structure of Dronpa caging of T7 RNAP, in red circles the C and N termini of the protein.
+
                                             <b>Figure 9: </b>  A) The structure of T7 RNAP binding DNA (PDB: 1t7p)  B)The prediction of the structure of Dronpa caging of T7 RNAP, in red circles the C and N termini of the protein.
 
                                              
 
                                              
 
                                     </span>
 
                                     </span>
Line 189: Line 189:
 
                  
 
                  
  
 +
  <section>
 +
                                <h1>
 +
                                Strategy III: Oligomerization of Dronpa competes with the assembly of other enzymes
  
 +
 +
                                        </h1>
 +
                      <div class="text1">
 +
                         
 +
                            <p>Many interesting proteins function as tetramers, for example, glutathione S-transferase, beta-glucuronidase, magnesium ion transporters such as CorA and export factors such as SecB from E Coli. Developing a strategy to optically control tetrameric proteins has remained challenging, due to their huge structure. In our project, we found it would be of great interest to develop a principle for controlling the activity of these proteins by light.
 +
The interaction between subunits forming a tetramer is determined by their rate of association and dissociation. By switching on/off Dronpa it’s altered between multimer and monomer structures. We hypothesized that by fusing 2 domains of dronpa in each subunit of a tetramer, the oligomerization of Dronpa would interfere with the assembly of the 4 subunits, thus allow the control of the tetrameric proteins.
 +
 +
To have a proof of concept we chose to work with β-galactosidase that functions as a homotetramer and its activity can be measured visually by X-Gal which produces a blue color that can easily be detected visually upon β-galactosidase activity. We made the following construct and we put it under testing.
 +
 +
 +
 +
                            </p>
 +
                            <div >
 +
                                    <img id="fig12" src="https://static.igem.org/mediawiki/2017/e/e1/Aya_figure_12.png"/>
 +
                                </div>
 +
                                    <span  class="image-span text-center">
 +
                                            <b>Figure12:</b>  construct of lacz-Dronpa fusion to test for β-galactosidase activity.
 +
 +
                                    </span>
 +
                           
 +
                            <p>
 +
                                 
 +
BWe tested the protein activity in vitro by the experiment indicated in [figure 13]. Our preliminary results [figure 14] suggest that β-galactosidase activity can be controlled by light, although there exists a background that indicates a leaky control.
 +
 +
                            </p>
 +
                            <div >
 +
                                    <img id="fig13" src="https://static.igem.org/mediawiki/2017/6/61/Aya_figure_13.png" />
 +
                                </div>
 +
                                    <span  class="image-span text-center">
 +
                                            <b>Figure 13: </b>  An overview of the experiment done to evaluate the activity of β-galactosidase-Dronpa fusion.
 +
                                           
 +
                                    </span>
 +
 +
                            <img id="fig14" src="https://static.igem.org/mediawiki/2017/6/61/Aya_figure_13.png" />
 +
                                </div>
 +
                                    <span  class="image-span text-center">
 +
                                            <b>Figure 14: </b> 
 +
                                           
 +
                                    </span>
 +
 +
                           
 +
                            <p>
 +
                                  The inactivation of T7RNAP was confirmed by using a reporter mrfp construct [figure 10] to indicate the activity of T7 RNAP as fluorescence output. By plating the cells overnight in dark and cyan conditions, no RFP was generated.
 +
 +
                            </p>
 +
                                             
 +
                        </div>
 +
                </section>
  
  

Revision as of 01:27, 2 November 2017

PROTEIN PHOTOCAGING

Introduction

Photoreceptors are valuable optogenetic tools which, upon coupling with other proteins, activate certain functions in a controlled spatial and temporal manner when exposed to the appropriate wavelength of light. However, the usage of photoreceptors suffers from many drawbacks including the toxicity of the light to the cells, photobleaching of the receptors and the delay in the response i.e. the time needed for transcription and translation of the target protein to be controlled-. The emergence of Fluorescent light-inducible proteins is an attractive alternative that doesn’t suffer from these drawbacks.

Dronpa is one of the reversible photoswitchable fluorescent proteins (RSFPs), these are proteins that are switched on and off reversibly by specific wavelengths. Dronpa is switched on by default “fluorescent” and is switched off when illuminated by cyan light (~500nm). Dronpa Fluorescence is recovered by shining violet light (~400nm)

put your image here
Figure 1: an illustration of the on/off switching of dronpa and the associated alternation between the monomer/dimer structures

The conformational changes that are associated with the on/off switching of Dronpa Lys145Asn has been used in a design that facilitates the optical control of protein activities. When Dronpa domains are fused to both termini of an enzyme of interest, the Dronpa domains form a tetramer and cage the enzyme leading to its inactivation. By Shining cyan light, Dronpa is switched off and the tetramer dissociates into monomers, as a result the caged enzyme is activated (1) (3).

put your image here
Figure 2:A fluorescent light-inducible protein design based on Dronpa Lys145Asn- From Zhou, X.X. and Lin, M.Z., 2013.

Results

1) Design of protein Caging:

In our design, we had two copies of Dronpa Fluorescent Protein with two BsaI cutting site in between to allow the insertion of our genes of interest .

Figure 3: construct design for 2 Dronpa domains

2) Molecular mechanism:

The enzyme of interest is placed between 2 copies of Dronpa fluorescent protein via a linker. By switching on Dronpa (violet light) the protein of interest is caged as the two copies would dimerize. And by switching off Dronpa (cyan light), the two copies would dissociate which will result in activation of the protein of interest.

Figure 4: Shining cyan and violet light using LEDS.

3) MutDronpa:

Using error prone PCR we have obtained several versions of Dronpa with several mutations from which we picked one version that interested us the most, as it had an R149H mutation which is located in the dimer interface. We proceeded in our experiments with 2 variants of Dronpa. The original version was annotated as wtDronpa and the mutated version was annotated as mutDronpa which has 2 mutations I4V and R149H in the first dronpa domain and an F78S mutation in the second domain.

Strategy I: Caging increase -instead of block- the activity of caged proteins:

Repressors bind DNA and setback transcription. In our project we developed a logic gate at the promoter level by creating dually repressed promoters using different combinations of the operators for TetR, P22 c2 and HK CI and it was interesting for us to test if these repressors can be controlled by light thus creating a light-inducible library of transcription factors. Dronpa hasn’t been used to control transcription factors, so we developed the following constructs to test if Dronpa can control proteins that function by dimerization.

Figure5: A diagram of the design of Dronpa-Repressors constructs.

By running a structure prediction test [figure 6], we could obtain some information regarding the expected behavior of the output of our design. In our design, the two Dronpa domains are connected to the repressors via long flexible linkers, which indicates that homodimers of repressors are likely to be formed even if caged by dronpa. The folding of the repressors that we are testing will be fast due to their small size and simple structure, which will make the dimerization of 2 copies of the repressors -before the complete folding of the second dronpa domains and caging the repressor- very likely. We expected in our design that the repressor homodimer will bind to its operator and once the second domain of Dronpa is fully folded, it will cage the already bound repressor to the DNA thus further stabilizing the repression when the violet light is shone.

Figure 6: Structure prediction of A) P22C2-dronpa fusion B)TetR-dronpa fusion C)HKCI-dronpa Fusion

To validate our design, we tested the three constructs in [figure 5] for both wtDronpa and mutDronpa with the logic gate of the dually repressed promoters in a cell free system giving us 96 combination.

Figure 7: In Vitro characterization of the activity of the repressors using cell free system

By illuminating our system with violet light, caging increase the repression (indicated by low mRFP levels) while cyan light decreases the repression (indicated by high mRFP levels) [Figure 7].

Strategy II: Caging control the protein activity by causing conformational changes:

T7 RNA polymerase (RNAP) transcribes only DNA downstream of a T7 promoter and it has a low error rate. Putting into account that T7 RNAP flexibility as it undergoes dramatic conformational changes during the transition from an initiation complex to an elongation complex. We hypothesized that adding two copies of Dronpa might control the activity of T7 RNAP by altering its conformation. To test this hypothesis we made the following construct:

Figure8: A diagram of the design of Dronpa-T7RNAP constructs.

By running a structure prediction test [figure 9], the prediction indicates the that the addition of the two dronpa domains is causing drastic changes in the structure of T7 RNAP. In the original T7 RNAP structure the C and N termini are adjacent, so fusing the 2 dronpa domains to both termini is changing its conformation.

Figure 9: A) The structure of T7 RNAP binding DNA (PDB: 1t7p) B)The prediction of the structure of Dronpa caging of T7 RNAP, in red circles the C and N termini of the protein.

The inactivation of T7RNAP was confirmed by using a reporter mrfp construct [figure 10] to indicate the activity of T7 RNAP as fluorescence output. By plating the cells overnight in dark and cyan conditions, no RFP was generated.

Strategy III: Oligomerization of Dronpa competes with the assembly of other enzymes

Many interesting proteins function as tetramers, for example, glutathione S-transferase, beta-glucuronidase, magnesium ion transporters such as CorA and export factors such as SecB from E Coli. Developing a strategy to optically control tetrameric proteins has remained challenging, due to their huge structure. In our project, we found it would be of great interest to develop a principle for controlling the activity of these proteins by light. The interaction between subunits forming a tetramer is determined by their rate of association and dissociation. By switching on/off Dronpa it’s altered between multimer and monomer structures. We hypothesized that by fusing 2 domains of dronpa in each subunit of a tetramer, the oligomerization of Dronpa would interfere with the assembly of the 4 subunits, thus allow the control of the tetrameric proteins. To have a proof of concept we chose to work with β-galactosidase that functions as a homotetramer and its activity can be measured visually by X-Gal which produces a blue color that can easily be detected visually upon β-galactosidase activity. We made the following construct and we put it under testing.

Figure12: construct of lacz-Dronpa fusion to test for β-galactosidase activity.

BWe tested the protein activity in vitro by the experiment indicated in [figure 13]. Our preliminary results [figure 14] suggest that β-galactosidase activity can be controlled by light, although there exists a background that indicates a leaky control.

Figure 13: An overview of the experiment done to evaluate the activity of β-galactosidase-Dronpa fusion.
Figure 14:

The inactivation of T7RNAP was confirmed by using a reporter mrfp construct [figure 10] to indicate the activity of T7 RNAP as fluorescence output. By plating the cells overnight in dark and cyan conditions, no RFP was generated.

- After light illumination, X-Gal dissolved in DMSO and diluted in PBS was added to to reach the final concentration of 5x

Dilution factor 1 1.25 1.66 2.5 5
Ul of Proteins 25 20 15 10 5
Ul ofPBS - 5 10 15 20

Ref:

Zhou, X.X., Chung, H.K., Lam, A.J. and Lin, M.Z., 2012. Optical control of protein activity by fluorescent protein domains. Science, 338(6108), pp.810-814.

Zhou, X.X. and Lin, M.Z., 2013. Photoswitchable fluorescent proteins: ten years of colorful chemistry and exciting applications. Current opinion in chemical biology, 17(4), pp.682-690.

Zhou, X.X., Fan, L.Z., Li, P., Shen, K. and Lin, M.Z., 2017. Optical control of cell signaling by single-chain photoswitchable kinases. Science, 355(6327), pp.836-842.


Centre for Research and Interdisciplinarity (CRI)
Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
Paris Descartes University
24, rue du Faubourg Saint Jacques
75014 Paris, France
bettencourt.igem2017@gmail.com